Literature DB >> 26241270

Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Abridged Republication of Guidelines From the International Federation of Gynecology and Obstetrics (FIGO).

Jaime Prat.   

Abstract

Mesh：

Year:  2015        PMID： 26241270     DOI： 10.1097/AOG.0000000000000917

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  25 in total

1.  Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.

Authors:  Mary L Disis; Matthew H Taylor; Karen Kelly; J Thaddeus Beck; Michael Gordon; Kathleen M Moore; Manish R Patel; Jorge Chaves; Haeseong Park; Alain C Mita; Erika P Hamilton; Christina M Annunziata; Hans Juergen Grote; Anja von Heydebreck; Jaspreet Grewal; Vikram Chand; James L Gulley
Journal:  JAMA Oncol       Date:  2019-03-01       Impact factor: 31.777

2.  Breast Microcalcifications as the Only Imaging Manifestation of Metastatic Serous Peritoneal Adenocarcinoma in the Breast.

Authors:  Mary Moon-Sun Liang; Sze Yiun Teo; Mihir Gudi; Swee Ho Lim; Thida Win
Journal:  J Radiol Case Rep       Date:  2019-10-31

3.  Long non-coding RNA MALAT1 is upregulated and involved in cell proliferation, migration and apoptosis in ovarian cancer.

Authors:  Liqin Wu; Xiaoyu Wang; Yuna Guo
Journal:  Exp Ther Med       Date:  2017-04-05       Impact factor: 2.447

Review 4.  The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review.

Authors:  J Hefner; H Csef
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

Review 5.  CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know-Radiology In Training.

Authors:  Maria Clara Fernandes; Ines Nikolovski; Kara Long Roche; Yulia Lakhman
Journal:  Radiology       Date:  2022-05-24       Impact factor: 29.146

6.  Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [18F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125.

Authors:  Ariel Glickman; Pilar Paredes; Núria Carreras-Diéguez; Aida Niñerola-Baizán; Lydia Gaba; Jaume Pahisa; Pere Fusté; Marta Del Pino; Berta Díaz-Feijóo; Eduardo González-Bosquet; Núria Agustí; Nuria Sánchez-Izquierdo; David Fuster; Andrés Perissinotti; Inmaculada Romero; Esther Fernández-Galán; Josep Lluís Carrasco; Blanca Gil-Ibáñez; Aureli Torné
Journal:  Eur Radiol       Date:  2021-09-29       Impact factor: 7.034

Review 7.  Clinical significance of microRNA-200 and let-7 families expression assessment in patients with ovarian cancer.

Authors:  Severyn Ferneza; Markiyan Fetsych; Roman Shuliak; Halyna Makukh; Natalia Volodko; Roman Yarema; Taras Fetsych
Journal:  Ecancermedicalscience       Date:  2021-06-14

8.  Flow cytometry-based analysis of tumor-leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer.

Authors:  Kazuya Takahashi; Kentaro Kurashina; Shin Saito; Rihito Kanamaru; Hideyuki Ohzawa; Hironori Yamaguchi; Hideyo Miyato; Yoshinori Hosoya; Alan Kawarai Lefor; Naohiro Sata; Joji Kitayama
Journal:  Cytometry B Clin Cytom       Date:  2020-12-04       Impact factor: 3.248

9.  Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.

Authors:  Wiebren A A Tjalma
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

10.  Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer.

Authors:  M Caroline Vos; Anneke A M van der Wurff; Johan Bulten; Roy Kruitwagen; Harrie Feijen; Toin H van Kuppevelt; Thijs Hendriks; Leon F A G Massuger
Journal:  Diagn Pathol       Date:  2016-04-02       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.